On August 1, 2018, the World Health Organization (WHO) reported that a new Ebola outbreak was detected in the eastern part of the Democratic Republic of Congo (DRC), about one week after having declared that a separate outbreak had ended in the western part of the country. This new outbreak is occurring in North Kivu and Ituri provinces, the most populated provinces in DRC, where a humanitarian crisis affecting over 1 million displaced people is ongoing. Health workers have begun vaccinating people in the districts to control the spread of the disease, though armed conflict in the areas is complicating control efforts. As of October 2, 2018, 162 people have contracted Ebola in North Kivu and Ituri provinces (including 19 health workers), 106 of whom have died (3 of whom were health workers).
This outbreak is the 10th Ebola outbreak in DRC since the disease was discovered in 1976, and it stands in stark contrast to the previous outbreak (Figure 1). The outbreak that began in May 2018 was contained and ended within two months after having infected 54 people, including 33 of whom died. In its second month, this outbreak has caused twice as many deaths and is continuing to spread. Issues complicating efforts to contain the current outbreak include the following:
Some opposition groups in parts of North Kivu are reportedly urging communities to hold protests against a perceived government effort to spread Ebola. Violence against safe burial, vaccination, and public health education teams has been reported in various parts of North Kivu, and resistance to health workers remains a challenge. Peter Salama, the WHO Deputy Director-General for Emergency Preparedness and Response, warned that if violence intensified and forced WHO and its partners to leave the region, then "we would have grave concerns that this outbreak would not be able to be well controlled in the coming weeks to months."
Source: Adjusted by CRS from World Health Organization, Ebola Outbreak Response in The Democratic Republic of The Congo, Briefing to Committee A at the World Health Assembly, Geneva, Switzerland, May 23, 2018.
Note: CRS adapted the graphic to include information on Ebola cases and deaths in May 2018 and to identify the location of North Kivu and its proximity to Uganda, Rwanda, and Burundi.
The WHO indicates that Uganda is facing an "imminent threat" of Ebola importation from the DRC and has already, in partnership with the Ugandan government, designated treatment facilities and prepositioned vaccines in Uganda. The risk of national and regional spread remains high. The WHO and its partners have supported the strengthening of Public Health Emergency Operations Centers in Rwanda, South Sudan, Tanzania, Uganda, and Zambia to aid in pandemic preparedness efforts.
In contrast to the 2014-2016 West Africa Ebola outbreak, the WHO response to the recent outbreaks was swift. On the same day that the outbreak was reported, WHO released $2 million from its Contingency Fund for Emergencies (CFE), deployed a team to the region, and activated an emergency incident management system. WHO also issued a $57 million appeal to control the outbreak. The international community exceeded the request and raised $63 million. The largest contributions were provided by Germany (€5 million), United Kingdom (£5 million), and the United States ($5.3 million). Other types of support included in-kind contributions for medical evacuations and intercountry air transport from Norway and the European Union, respectively, and technical assistance from Germany, Guinea, the United Kingdom, and the United States.
The DRC's Ministry of Health, WHO, and other stakeholders took several steps to contain the outbreak. Notably, a new vaccine, which was used for the first time in the field during the 2014-2016 West Africa Ebola outbreaks, was provided to all primary and secondary contacts to prevent disease transmission. Merck initially provided more than 7,500 doses for the vaccination effort. WHO report that almost 12,000 people have been vaccinated and an additional 39 people have received investigational drugs. There is no approved treatment for Ebola. Twenty-seven of the 39 people infected with Ebola who received the experimental treatments survived. This marks the first time in which investigational drugs were used in the field during an outbreak.
In May 2018, the United States committed to provide $8.0 million in support of Ebola control efforts in the country, drawing on $5.0 million in FY2017 appropriations for the U.S. Agency for International Development (USAID)-administered Global Health Program (GHP) funding and $3 million in GHP funds appropriated in FY2015 for Ebola response in West Africa. Roughly $5.0 million of the funds were provided to WHO for case management, entry screenings, diagnosis testing, and support for other laboratory functions. About $2.0 million was for the United Nations Children's Fund (UNICEF) to implement Ebola awareness communication campaigns and water, sanitation, and hygiene (WASH) projects. An estimated $700,000 was used by the International Federation of the Red Cross/Red Crescent Societies (IFRC) for promoting safe burial practices and Ebola prevention education campaigns. In addition, the U.S. Centers for Disease Control and Prevention (CDC) provided technical assistance for communications, logistics, operational and personnel support, laboratory capacity building, and the development and implementation of an outbreak response plan.
On June 5, the White House withdrew proposed rescissions of $252 million in unobligated emergency International Disaster Assistance (IDA) funds appropriated in 2015 to control the West Africa Ebola outbreak and bolster response capacity in affected countries. The funds were provided by Congress in 2015 to control the 2014-2015 West Africa Ebola outbreak. Excess funds were intended to be made available for future Ebola control efforts.
On October 1, 2018, USAID announced that it had deployed a Disaster Assistance Response Team (DART) to bolster ongoing U.S. efforts in the country. The DART team is composed of disaster and health experts from USAID and the CDC and is expected to expand healthcare services, water and sanitation interventions, and carry out other disease prevention measures.